BeesFree Inc. Files Technology Patent in Argentina

        Print
| Source: BeesFree Inc.

WEST PALM BEACH, Fla., Feb. 16, 2012 (GLOBE NEWSWIRE) -- BeesFree, Inc. (OTCBB:BEES) today announced that the Company has filed a Technology Patent with Argentinean authorities regarding its innovative technology which aims to mitigate the effects of Colony Collapse Disorder (CCD) and potentially serve as a cure to CCD.

More and more frequently, Honeybees have been mysteriously disappearing across the planet and vanishing from their hives. Known as Colony Collapse Disorder or CCD, this phenomenon has created a crisis within in the beekeeping community, a critical industry responsible for a majority of the world's fruit and vegetable production. In fact, commercial honeybee operations pollinate crops that make up one out of every three bites of food on our nation's tables.

BeesFree CEO Mario Sforza stated, "Now that we have formally filed the patent application in Argentina, we are able to ramp up our aggressive marketing and sales programs. The market in the Argentina bee community is quite large and our discussions with local beekeepers have been quite promising. We look forward to introducing our solutions across all of South America beginning with Argentina."

This patent pending technology is designed to work and be effective on a global scale as honeybees' physiology and behavioral patterns are quite similar across different environmental and climatic conditions. BeesFree has previously filed a global patent surrounding this technology, but as Argentina is not a member of the Patent Cooperation Treaty (PCT), the Company filed for PCT extension with the local Patent Office on February 14, 2012. BeesFree is represented by Laura Berti & CIA, an international law firm located in Buenos Aires that specializes in Intellectual Property Right (IPR) issues.

BeesFree is a unique conglomerate of researchers, beekeepers, businessmen and financiers who leveraged early recognition of a global honeybee problem known as Colony Collapse Disorder into the first known, commercially viable cure for the condition. BeesFree's patent pending formula and delivery system are presently the only products available to combat the phenomenon in a global market whose size measures between $2 and $3 billion. The company's Headquarters are in the US and its corporate laboratories in Rome, Italy. The Company has developed a global marketing strategy currently focused on South America, South Africa, China, India and where its initial product launch will be met with a less restrictive regulatory regime.

About BeesFree, Inc. (OTCBB:BEES)

BeesFree is a technology company with global reach, which develops and commercializes innovative solutions for the beekeepers communities on a worldwide scale. For more information, please visit www.beesfree.biz.

Forward-Looking Statements

Statements about the future expectations of Bees Free, Inc. and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as that term is defined in the Private Securities Litigation Reform Act of 1995. Bees Free, Inc. intends that such forward-looking statements shall be subject to the safe harbors created thereby. Since these statements involve certain risks and uncertainties and are subject to change at any time, Bees Free actual results could differ materially from expected results.

BeesFree, Inc.
2101 Vista Parkway, Suite 4033
West Palm Beach, FL
CEO - Mario Sforza